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Abstract
SHANK3, a synaptic scaffold protein and actin regulator, is widely expressed outside of the 
central nervous system with predominantly unknown function. Solving the structure of the 
SHANK3 N-terminal region revealed that the SPN-domain is an unexpected Ras-association 
domain with high affinity for GTP-bound Ras and Rap G-proteins. The role of Rap1 in integrin 
activation is well established but the mechanisms to antagonize it remain largely unknown. Here, 
we show that SHANK1 and SHANK3 act as integrin activation inhibitors by sequestering active 
Rap1 and R-Ras via the SPN-domain and thus limiting their bioavailability at the plasma 
membrane. Consistently, SHANK3 silencing triggers increased plasma membrane Rap1 activity, 
cell spreading, migration and invasion. Autism-related mutations within the SHANK3 SPN-
domain (R12C and L68P) disrupt G-protein interaction and fail to counteract integrin activation 
along the Rap1/RIAM/talin axis in cancer cells and neurons. Altogether, we establish SHANKs as 
critical regulators of G-protein signalling and integrin-dependent processes.
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Introduction
Integrins are heterodimeric transmembrane receptors that couple the extracellular matrix 
(ECM) to the actin cytoskeleton and undergo conformational switching from a low-affinity 
“inactive” to a high-affinity “active” state. In the active conformation integrins enhance cell 
signalling and inappropriate integrin activation is linked to several pathologies including 
inflammation and cancer1. Hence, understanding integrin activity regulation is of major 
clinical relevance. Integrins are also crucial regulators of important processes in the brain 
such as neuronal cell migration, axonal outgrowth and synaptic plasticity2 but the role of 
integrin activity regulation in these processes remains to be fully investigated.
Talin recruitment to the  ?-integrin tail triggers integrin activation and is regulated through 
the activity of the Rap1 GTPase and its effector Rap1-interacting adaptor molecule 
(RIAM)3–5. Integrin activity can be counterbalanced by integrin inactivating proteins such 
as SHARPIN, ICAP-1 and filamin1,6,7, all of which interact with integrins and directly or 
indirectly interfere with talin-mediated integrin activation. However, potential mechanisms 
to block integrin activation at the level of Rap G-proteins remain unidentified.
SH3 and multiple ankyrin repeat domains (SHANK) 1-3 are a family of scaffold proteins 
found in the postsynaptic density (PSD) of excitatory synapses and are indispensable for 
normal brain function8,9. In addition, SHANK proteins are expressed in peripheral organs 
with largely unknown functions. Genetic alterations in SHANK3 are responsible for a 
spectrum of neuropsychiatric disorders, including autism spectrum disorders (ASD), 
schizophrenia, intellectual disability and manic-like behaviour10–16 and chromosomal 
deletions of the region containing SHANK3 cause Phelan-McDermid syndrome (22q13 
deletion syndrome) which manifests as neurological symptoms and affects many peripheral 
organs including the dermis, congruent with the wide tissue-distribution of SHANK317,18. 
Recently, autism-like symptoms of Shank3-deficient mice were reversed by targeting actin 
regulators or Akt signalling19,20 and adult restoration of Shank3 in mice improved many of 
the autistic-like symptoms21. Thus, SHANK3 seems to actively contribute to signalling and 
the regulation of the cell cytoskeleton during and post development.
Results
SHANK1 and SHANK3 inhibit integrin activation
We previously performed a druggable genome-wide RNAi screen in 13 different human cell 
lines and analysed integrin activity using monoclonal anti- ?1 integrin antibodies (9EG7 and 
12G10) that specifically recognize the active receptor conformation22. Re-evaluation of 
these data revealed increased integrin activation (detected with either one or both of the 
antibodies) following SHANK1 or SHANK3 silencing in nine and in five out of the 13 cell 
lines tested, respectively (Fig. 1a). Although both SHANK1 and SHANK3 are major PSD 
scaffolding proteins in excitatory synapses, they are also widely expressed outside of the 
nervous system with currently unknown functions (publicly available GTEx portal data; Fig. 
1b).
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To validate a role for SHANK1 and SHANK3 in inhibiting integrin activation we employed 
a dual colour flow cytometric assay to measure cell-surface active integrins (based on the 
binding of a recombinant integrin ligand fragment, fibronectin [FN] repeats 7-10) relative to 
total cell-surface integrins in CHO cells23,24. Expression of rat Shank3-mRFP (Fig. 1c) or 
rat Shank1-GFP (Supplementary Fig. 1a) significantly reduced integrin activity, compared to 
mRFP or GFP alone (Fig. 1c and Supplementary Fig. 1a) without altering total  ?1-integrin 
surface levels. Moreover, the magnitude of Shank-mediated integrin inhibition was 
comparable to the effect of overexpressing SHARPIN-GFP (Fig. 1c), a known  ?1-integrin 
inhibitor in several cell types7,25,26. To confirm these findings we analysed integrin activity 
in the human HEK293 and MDA-MB-231 cell lines with opposing patterns of SHANK3 and 
SHANK1 expression (Supplementary Fig. 1b, 1c). Silencing of SHANK3 in SHANK3–
expressing HEK293 cells or SHANK1 in SHANK1-expressing MDA-MB-231 cells 
(Supplementary Fig. 1d) triggered a significant increase in cell-surface active integrin levels 
(Fig. 1d,e and Supplementary Fig. 1e,f) without affecting total cell-surface receptor 
expression. SHANK3, or SHANK1, silencing was nearly as efficient in activating  ?1-
integrins as Mn2+ (Fig. 1d and Supplementary Fig. 1e) which binds to the integrin 
ectodomain and activates  ?1-integrin heterodimers via an outside-in mechanism27. 
Importantly, reintroduction of rat Shank3-mRFP or rat Shank1-GFP reversed the increased 
integrin activity in SHANK3- or SHANK1-silenced cells and reduced integrin activity levels 
in control-silenced cells (Fig. 1e and Supplementary Fig. 1f). Thus, the ability of SHANK3- 
and SHANK1-targeted siRNAs to increase  ?1-integrin activity was specifically due to the 
loss of each SHANK isoform rather than off-target effects.
To explore whether murine Shank3 regulates integrin activity as well, we isolated mouse 
mammary epithelial cells (MMECs), known to express Shank328 (Supplementary Fig. 1g), 
and mouse mammary fibroblasts (MMFs) lacking Shank3 (Supplementary Fig. 1g), from 
WT Shank3 挃?+/+ and Shank3 挃?-/- mutant mice (specifically lacking the long  挀 (containing 
SPN, Ank and SH3 domains) and  ?(containing Ank and SH3 domains) isoforms of 
SHANK3)29,30 We observed markedly higher active integrin levels in MMECs, but not 
MMFs, isolated from Shank3 挃?-/- compared to WT mice (Shank3 挃?+/+) (Fig. 1f and 
Supplementary Fig. 1h,i). Taken together, these data indicate that SHANK1 and SHANK3 
function as inhibitors of  ?1-integrin activation.
SHANK1 and SHANK3 localize to membrane ruffles with inactive integrins
Next we investigated the subcellular localization of SHANKs in cells. In the absence of 
suitable reagents to detect endogenous SHANKs with immunofluorescence we expressed 
Shank3-mRFP (Fig. 1g; Supplementary figure 1j,k) or Shank1-GFP in MDA-MB-231 cells 
(Supplementary Fig. 1j). Both SHANK proteins localized to the periphery of the cell in 
actin-rich membrane ruffles positive for the membrane marker CAAX-GFP and the inactive 
integrin receptor (Fig. 1g and Supplementary Fig. 1j) as well as to the nucleus (the possible 
nuclear function of SHANKs was not investigated here further). Conversely, no co-
localisation was observed between SHANKs and ECM-bound active integrins 
(Supplementary Fig. 1k). Membrane recruitment of SHANK3 was validated further with 
biochemical membrane fractionation, demonstrating SHANK3 in both the cytoplasmic and 
plasma membrane fractions (Fig. 1h), and with live-cell imaging showing dynamic 
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localization of Shank3-mRFP to folding membrane areas (Fig. 1i and Supplementary video 
1). Thus, SHANK1 and SHANK3 appear to predominantly localize to unattached membrane 
ruffles together with inactive integrin and actin.
SHANK1 and SHANK3 inhibit cell adhesion and spreading
Consistent with increased integrin activation (Fig. 1), SHANK3 silencing in HEK293 cells 
or SHANK1 silencing in MDA-MB-231 cells promoted cell adhesion to a fibronectin-
collagen matrix over time as measured with the xCELLigence apparatus (Fig. 2a and 
Supplementary Fig. 2a). In addition, SHANK3-silenced HEK293 cells generated 
significantly more, yet smaller, adhesions (Fig. 2b-2e). Interestingly, SHANK3 silencing 
also appeared to affect cell spreading. Downregulation of either SHANK isoform was 
sufficient to trigger a significant increase in cell area on the fibronectin-collagen-coated 
surface at 20 and 60 min post plating compared to control-silenced cells (Fig. 2f,g and 
Supplementary Fig. 2b,c). Enhanced cell spreading was even more evident in cells plated on 
spatially restricted micropattern lines where SHANK3 silencing resulted in significantly 
longer cell lengths compared to the control (Fig. 2h,i). Thus, SHANK1 and SHANK3 
negatively regulate integrin-mediated adhesion and spreading in cells.
SHANK-mediated integrin inhibition is SHARPIN independent
We next sought to explore how SHANKs regulate integrin activity. SHARPIN binds to the 
ARR domain of SHANKs31,32. To determine whether SHANK-mediated integrin 
inactivation is SHARPIN dependent, we expressed SHARPIN- or Shank1-GFP in mouse 
embryonic fibroblasts (MEFs) generated from WT or SHARPIN-null (cpdm) animals7 and 
measured surface levels of active (FN 7-10 binding), relative to total,  ?1-integrin. As 
expected, expression of both SHARPIN-GFP and Shank1-GFP reduced  ?1-integrin 
activation in WT MEFs (Supplementary Fig. 2d). Interestingly, Shank1-GFP expression 
decreased  ?1-integrin activation in cpdm MEFs to approximately the same extent as in WT 
MEFs (Supplementary Fig. 2d) suggesting that SHARPIN is dispensable for SHANK-
mediated integrin inactivation.
Autism-linked mutations in SHANK3 impair its integrin inhibitory function
The N-terminal SPN domain of SHANK1 and SHANK3 (Fig. 3a) is highly conserved32 and 
missense mutations in the SPN domain of SHANK3 (R12C and L68P) have been detected in 
patients with autism33,34, highlighting the importance of the SPN domain for the proper 
function of SHANK3. In line with this notion, we found that expression of SHANK mutants 
(Shank3R12C or Shank3L68P) harbouring the identified ASD mutations32 in SHANK3-
silenced cells failed to rescue the increase in integrin activation triggered by loss of 
SHANK3 (Fig. 3b). In contrast, re-expression of Shank3 WT in the same cells completely 
restored integrin activity back to control levels (Fig. 3b). Furthermore, overexpression of the 
SPN-domain alone (SPN WT) was sufficient to significantly inhibit integrin activity in CHO 
cells (Fig. 3c). The L68P mutation significantly, and the R12C mutation partially, impaired 
SPN-domain mediated integrin inhibition (Fig. 3c). An intact SPN domain was also critical 
for the ability of SHANK3 to regulate cell adhesion (Fig. 3d) and cell spreading (Fig. 3e). 
Unlike SHANK3 WT, SHANK3L68P failed to rescue SHANK3-silencing-induced effects 
on these processes. Thus, an intact SPN domain is a prerequisite for SHANK-dependent 
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inhibition of integrin activity and the L68P mutation is more disruptive to SPN-domain 
activity than the R12C mutation.
Given the apparent functional importance of the ASD-associated SHANK3 mutations in 
integrin activity regulation, we investigated the effects of SHANK3 WT and L68P mutant in 
neurons. Overexpression of SHANK3 WT, but not the L68P mutant, in Shank3 挃?-/- cortical 
neurons plated on laminin, inhibited  ?1-integrin activity in neuronal growth cones, structures 
regulated by integrins and integrin down-stream signalling35,36 (Fig. 3f,g). In addition, 
expression of the SPN WT, but not the SPNL68P, inhibited integrin activity in growth cones 
of differentiating neuroblastoma cells on laminin (Supplementary Fig. 3a,b). Thus, 
SHANK3 inhibits  ?1-integrins also in neuronal cells.
Three-dimensional structure of the SHANK SPN-ARR region
To gain further insight into the role of the SHANK SPN domain in regulating integrin 
activity we determined the structure of the SPN-ARR region (the SPN domain is likely to 
form a compact unit with the adjacent ARR domain through intramolecular interactions32) 
by crystalizing the N-terminal fragment of SHANK3 (residues 1-348) and solving the 
structure by molecular replacement using two repeats from the core ankyrin domain of the 
crystal structure of human ankyrin-R (PDB: 1N11) as a template. The resulting structure, 
containing only 1 chain in the asymmetric unit and comprising residues 2-347 of SHANK3, 
was refined to 2.2Å; no electron density was detected for residues 1 and 348. Data collection 
and refinement statistics are given in Supplementary Table 1.
The structure of the SPN-ARR fragment demonstrated two distinct domains separated by a 
19-residue linker with a well-defined conformation (Fig. 3h). The C-terminal ARR domain 
(residues 113-337) consists of seven canonical helix-turn-helix- ?-hairpin/loop ankyrin 
repeats arranged in a curved solenoid structure. The loop region of each repeat forms a  ?-
hairpin extending at 90°-angle from the helices towards the centre of the solenoid, typical 
for ARR domains 37. The  ?-hairpins of the repeats form a continuous flat surface that 
covers one end of the solenoid structure. The SPN domain (residues 8-93) positioned on top 
of the ARR  ?-hairpin surface has a ubiquitin-like fold (Ubl) closely resembling the Ubl 
within the talin F0 domain38,39 (Fig. 3i and Supplementary Fig. 3c). The SPN domain 
makes charged and polar contacts with the outer surface of the  ?-hairpins of repeats 2 and 3 
(Fig. 3j). The N-terminal part of the linker region connecting the SPN and ARR domains 
runs along the ARR  ?-hairpin surface, making a range of polar contacts (Fig. 3j). The C-
terminal region of the linker folds into a 2-turn  ?-helix that packs against the outer end of 
the ankyrin repeat 1.
NMR-studies confirmed that the SPN-ARR region of SHANKs exist as an integrated unit in 
solution (see Supplementary Fig. 3d for the data and a detailed description).
Structure of SHANK3 SPN-ARR reveals a previously uncharacterized Ras/Rap-association 
(RA) domain
The similarity between the SHANK SPN and talin F0 structures, and the reported interaction 
between talin F0 and Rap139,40, prompted us to investigate whether SHANK SPN is an RA 
domain interacting with Ras and Rap GTPases. Sequence alignment of SHANK1 and 
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SHANK3 SPN domains with the well-characterized RA domains of RalGDS, Raf and Byr 
revealed the presence of consensus Ras/Rap-recognizing positive charges (residues R12 and 
K22) in the  ?1 and  ?2 strands of both SHANK1 and SHANK3 isoforms and a distinctive 
distribution of hydrophobic residues in the same region that are typically associated with RA 
domains41 (Fig. 4a). Furthermore, the Ras/Rap recognition side-chains of the SPN and 
RalGDS RA domains are well aligned in space (Fig. 4b). The only deviation from the 
consensus is the substitution of a positive charge, corresponding to position 52 in RalGDS, 
with an alanine in SHANK1 and SHANK3. However, other exposed positive charges (R38 
or R25) in the vicinity of R12 and K22 may compensate for the missing charge in the  ?1-
helix of the SHANK proteins (Fig. 4b,c). These data strongly suggest that SHANK SPN 
belongs to the RA family of Ubl domains.
The SHANK SPN domain is a functional RA domain as it coimmunoprecipitated with WT 
and constitutively active (G12V mutant) forms of H-Ras but not with the dominant negative 
H-Ras S17N variant (Fig. 4d). Thus, SHANK3 preferentially binds to the GTP-bound, active 
H-Ras. Additionally we found that the SHANK3 SPN domain interacts with several Ras and 
Rap proteins in their constitutively active and WT forms (Fig. 4e). However, in line with the 
notion that RA domains are promiscuous in terms of binding to several different Ras family 
members, but not Rho G-proteins, SHANK3 SPN did not interact with Rac1-GTP or Cdc42-
GTP (Supplementary Fig. 4a).
Autism-associated mutations in SHANK3 SPN impair Ras and Rap binding
Next we predicted the potential effects of ASD-related mutations by superimposing the 
SHANK3 SPN structure on the RalGDS RA domain in complex with Ras (PDB ID 1LFD). 
The model demonstrated that most of the key ion-pair and polar interactions at the interface 
are preserved in SHANK3. In this model the position of the SHANK3 SPN R12 side-chain 
is optimal for forming an ion-pair with E37 of Ras (Fig. 4f). Thus, the R12C mutation 
identified in ASD is expected to significantly reduce Ras binding. The second ASD mutation 
in the SPN domain, L68P, affects one of the key residues of the hydrophobic core (Fig. 3h) 
and is expected to disrupt the SPN fold, potentially causing loss of Ras interaction. As 
predicted from these structural analyses, the R12C and L68P ASD mutations within the SPN 
domain disrupted SHANK3 SPN domain interaction with active (G12V mutant) Ras as well 
as Rap1 variants (Fig. 4g,h), even though SPN R12C retained partial binding to Rap1b in 
pull-downs (Fig. 4g,h).
Accordingly, isothermal titration calorimetry (ITC) measurements with purified recombinant 
proteins indicated a very strong interaction between SHANK3 SPN-ARR and Rap1b-GTP 
(Kd = 0.2 ± 0.05 μM) (Fig. 4i). In comparison the Kd for SPNR12C binding to Rap1b was 
2.2 ± 0.26 μM, indicating a 10-fold reduction in affinity towards Rap1b (Fig. 4j), in line with 
the immunoprecipitation and modelling data. The interaction between WT SPN with H-Ras-
GTP was weaker (Kd = 3.3 ± 0.14 μM) (Supplementary Fig. 4b) and further reduced in the 
presence of the R12C mutation, and no interaction was observed with H-Ras-GDP 
(Supplementary Fig. 4c-e). The interaction between SHANK1 SPN and H-Ras-GTP, 
although weaker (Kd = 5.9 ± 0.73 μM), was within the range of affinities determined for RA 
domains (Supplementary Fig. 4f)41. The enthalpy of SHANK3 SPN interaction with Rap1-
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GTP was significantly lower than that observed with H-Ras-GTP (Supplementary Fig. 4g), 
suggesting stronger ion-pair interactions or formation of additional hydrogen bonds at the 
interface between the SHANK SPN domain and Rap1-GTP. We could not ascertain the 
effect of the ASD-related L68P mutation in ITC experiments as we were unable to produce 
soluble mutant protein. However, this insolubility may point towards a role for L68 in the 
folding of the SPN domain. Taken together these data indicate that the SPN domain of 
SHANK interacts with Ras and Rap in a manner similar to other RA domain-containing 
proteins and that the primary effect of ASD mutations is a loss of interaction with small G-
proteins.
SHANK3 interferes with integrin activation by sequestering Rap1a and R-Ras
Active small GTPases Rap1 4, 42–45 and R-Ras 46–48 activate integrins via inside-out 
signalling. To explore whether  ?1-integrin inhibition by SHANK3 is Rap1- and R-Ras-
dependent we performed the flow cytometric-based integrin activity assays in HEK293 cells. 
Expression of a constitutively active Rap1a (Rap1Q63E) or constitutively active R-Ras (R-
RasG38V) enhanced integrin activity (Fig. 5a and Supplementary Fig. 5a). Co-expression of 
Shank3-mRFP inhibited the ability of both Rap1Q63E and R-RasG38V to augment  ?1-
integrin activity which was comparable to control levels (Fig. 5a and Supplementary Fig. 
5a). The ability of Mn2+ to induce integrin outside-in activation is dependent on active Rap1 
availability in cells49. Accordingly, we find that Mn2+-induced integrin activity is 
significantly impaired in Shank3-mRFP overexpressing CHO cells (Supplementary Fig. 5b). 
Active Rap1a-induced integrin activation promotes marked cell spreading and flattening50. 
Consistent with the ability of SHANK3 to attenuate Rap1-dependent integrin activation, co-
expression of SHANK3 with Rap1 fully reversed the cell spreading phenotype (Fig. 5b and 
5c). Notably, the Rap-binding defective Shank3L68P and Shank3R12C mutants failed to 
counteract Rap1Q63E- or R-RasG38V-mediated integrin activation (Fig. 5a and 
Supplementary Fig. 5a). In hippocampal neurons integrin ligands stimulate 51 and SHANK3 
overexpression suppresses 52 the formation of new filopodia. We found that overexpression 
of Shank3 WT-GFP, but not the L68P mutant, inhibits filopodia number in MAP2-positive 
rat hippocampal neurites (Fig. 5d and 5e). Furthermore, WT SPN-GFP overexpression 
reduced filopodia number in neurites of differentiating neuroblastoma cells in comparison to 
GFP (Fig. 5f, g). However, the number of neurites, in addition to neurite length and 
branching, was not significantly affected by SHANK3 WT or L68P overexpression 
(Supplementary Fig. 5c), in agreement with the normal brain architecture reported for most 
Shank3-deficient mouse models53. Importantly, pharmacological inhibition of Rap154,55 
reverted integrin activity (Fig. 5h) and cell spreading (Fig. 5i,j) in SHANK3-silenced cells 
back to control levels, suggesting that SHANK3 regulates integrin activity and cell 
spreading in a Rap1-dependent manner. These data suggest that SHANK3 antagonizes 
Rap1a- and R-Ras-induced integrin activation and signalling.
Rap1-GTP targeting to the plasma membrane is essential for RIAM recruitment and talin-
mediated integrin activation4. In line with the ability of SHANK3 to counteract active Rap1-
dependent signalling in cells, we found significant colocalization between Shank3-mRFP 
and Rap1Q63E-GFP especially in membrane ruffles of cells (Fig. 6a). In addition, SHANK3 
silencing in cells markedly increased Rap1 levels in the plasma membrane fraction (Fig. 6b) 
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and triggered a marked enrichment of active Rap1 (Raichu-Rap1 fluorescence resonance 
energy transfer (FRET) probe 56) at the cell periphery close to the plasma membrane 
compared to a more uniform distribution of active Rap1 in control cells (Fig. 6c-e). This was 
due to altered Rap1 localization in cells as total Rap1-GTP levels in cells were not 
significantly altered upon SHANK3 silencing (Supplementary Fig. 6). Thus, SHANK 
expression appears to regulate the bioavailability of active Rap1 particularly on the plasma 
membrane.
SHANKs reduce integrin-talin complexes and regulate adhesion dynamics in cells
Interestingly, using the proximity ligation assay (PLA), we observed that SHANK3 silencing 
also promotes talin recruitment to  ?1-integrin (Fig. 7a,b). Furthermore, endogenous talin co-
immunoprecipitated with  ?1-integrin more efficiently in SHANK3-silenced cells (Fig. 7c; 
2.1 ± 0.7 fold increase, n = 3). Live-cell imaging revealed that depletion of SHANK1 
significantly enhanced talin recruitment to newly forming membrane protrusions in MDA-
MB-231 cells (Fig. 7d,e and Supplementary Video 2). In addition, SHANK1 silencing 
reduced the lifetime of paxillin-positive focal adhesions (Fig. 7f,g), corroborating our data 
from fixed cells displaying more small adhesions and faster cell spreading. Altogether, these 
data suggest that SHANK-mediated segregation of Rap1 away from the plasma membrane 
affects talin recruitment to integrin tails and thus impedes integrin activation. However, 
whether SHANKs directly affect Rap1/RIAM/talin complex formation remains to be 
investigated.
SHANK3 attenuates cell migration and invasion
Increased integrin activity is implicated in altered cell migration as well as enhanced cancer 
cell invasion and metastasis7,57,58. To assess the role of SHANKs in cell migration we 
analysed motility of SHANK-silenced cells in 2D. Time-lapse imaging revealed that 
depletion of SHANK3 in HEK293 cells or SHANK1 in MDA-MB-231 cells promotes a 
significant increase in migration velocity and a converse decrease in directionality of 
migration (Fig. 8a-c, Supplementary Fig. 7a-c). The effect of SHANK1 silencing on 
migration was fully reversed upon re-expression of Shank1-GFP (Fig. 8d-e). Previous work 
has linked increased random motility in 2D to enhanced cancer cell invasion in 3D59. In line 
with this notion we observed that SHANK1 silencing significantly promoted cell invasion 
into collagen hydrogels (Fig. 8f,g). Thus, increased integrin activity in SHANK-silenced 
cells promotes cell spreading, random migration and 3D invasion demonstrating that 
SHANKs are biologically important regulators of integrin function.
Discussion
Regulation of integrin activity is of central importance to human health1. The critical role of 
Rap1 in the final steps of integrin activation is well-established5; active Rap1 recruits RIAM 
and talin to the plasma membrane to facilitate integrin activation. However, mechanisms to 
fine-tune this activation or to antagonize it are not fully understood. Here we describe that 
scaffold proteins SHANK1 and SHANK3 act as negative regulators of integrin activity in 
several cell types and consequently interfere with cell adhesion, spreading, migration and 
invasion (Fig. 8h), and with filopodia formation in neurites. Furthermore, we demonstrate 
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that ASD-linked SHANK3 mutants are functionally deficient in binding to active Ras family 
members Rap1 and R-Ras and in mediating integrin inhibition.
The crystal structure of the SHANK3 N-terminal SPN-ARR region confirmed the 
intramolecular interaction between both domains detected previously32. More importantly, 
it allowed us to elucidate the molecular mechanism by which SHANKs regulate integrin 
activity: (1) the SPN is an RA domain most similar to the N-terminal F0 motif of talin; (2) 
the SHANK SPN domain binds active, GTP-bound forms of H-Ras, Rap1 and other Ras 
subfamily members with high affinity; (3) ASD-related mutations in residues R12 and L68 
in the SHANK3 SPN domain impair binding to Ras proteins and the ability to antagonize 
 ?1-integrin activity in cells. Thus, the primary mechanism of SHANK-dependent integrin 
antagonism most likely stems from the ability to interfere with Rap1 or R-Ras effector 
binding through direct competition (Fig. 8h). It is important to note that, unlike the specific 
integrins expressed on leukocytes or platelets, Rap1 is not absolutely essential for  ?1-
integrin activation and a significant pool of  ?1-integrin remains active in adherent cells even 
once Rap1 is inhibited1,7. Thus, several pathways, in addition to the Rap1-RIAM-talin axis, 
are likely to be involved in the spatio-temporal fine-tuning of  ?1-integrin activity in adherent 
cells at any given time.
ECM ligands and specific adhesion receptors such as integrins are also important in the 
central nervous system, in dendritic spines and synapses60. Autism-like deficits of Shank3-
deficient mice can be rescued by targeting the actin regulators Rac and cofilin20, by re-
expressing Shank3 in adult mice21 or by inhibiting Akt signalling19. Given the ability of 
integrins to regulate all of these proteins, our identification of a potential role for SHANK 
proteins in regulating integrin activity in neuronal growth cones is most likely relevant to the 
neurodevelopmental disorder of these mice.
Our observation that SHANKs antagonize integrin activation, by limiting active Rap1 
bioavailability on the plasma membrane, provides a significant advance to our understanding 
of integrin activity regulation. However, SHANK3-mediated control of Ras and Rap may 
contribute to integrin-independent pathways as well. SHANK3 is a major scaffold proteins 
within the PSD of dendritic spines61. Ras activation promotes spine growth, while Rap1 
induces spine shrinkage62. Thus, sequestration of the activated forms of G-proteins may 
contribute to maintaining the balance between Ras and Rap1 activities given that the R12C 
mutation compromises the effect of SHANK3 overexpression on spine size and synaptic 
transmission52,63. Furthermore, the ability of SHANK1 and SHANK3 to sequester active 
Ras- and Rap-family members is likely to be important in other biological contexts 
including Ras-driven human carcinomas.
Methods
Cell culture
CHO (Chinese hamster ovary) cells were maintained in Alpha-MEM medium (Sigma-
Aldrich) supplemented with 5% fetal bovine serum (FBS, Gibco) and 2 mM L-glutamine 
(Sigma-Aldrich). HEK293 (human embryonic kidney, ATCC) cells were grown in DMEM 
(Dulbecco’ s modified Eagle’ s medium, Sigma-Aldrich) supplemented with 10% FBS and 2 
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mM L-glutamine. MDA-MB-231 (triple-negative human breast adenocarcinoma, ATCC) 
cells were maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine, and 1% 
non-essential amino acids (Sigma-Aldrich). Immortalized mouse embryonic fibroblasts 
(MEFs) isolated from wild-type and SHARPIN-null (cpdm) mice have been described 
previously 7. MEFs were cultured in DMEM supplemented with 10% FBS, 2 mM L-
glutamate, 1 mM sodium pyruvate (Sigma-Aldrich), 1% non-essential amino acids and 
1:100000  ?-mercaptoethanol (Sigma-Aldrich). SK-N-BE-2 neuroblastoma cells (ATCC) 
were maintained in DMEM:HAM’ s F-12 medium supplemented with 10% FBS, 2 mM 
glutamine and 1% non-essential amino acids. All cells were routinely tested for mycoplasma 
contamination. No cell lines used in this study were found in the database of commonly 
misindentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines 
were not authenticated.
Mice and rats
Shank3 挃?-deficient mice (Shank3 挃?−/−) were generated by Genoway (Lyon, France) and 
raised on a C57BL/6 background, as described previously 29. Mice were kept in 
conventional open cages in pathogen-free barriers under normal food and lighting 
conditions. WT and Shank3 挃?−/− animals were obtained from heterozygous mating. 
Shank3 挃?−/−embryos for neuronal culture were obtained from mating of Shank3 挃?- 
deficient parents. Animals were genotyped by PCR as described 29. In experiments using rat 
neuronal cultures, cells were isolated from Wistar rat (Charles River) embryos. For each 
experiment, one pregnant rat (4-5 months old) was sacrificed and neurons were prepared 
from all embryos present, regardless of gender (14-16 embryos). All mouse and rat 
procedures were performed in compliance with the guidelines for the welfare of 
experimental animals issued by the Federal Government of Germany and the Finnish 
Government, and covered by animal license Org766 (Hamburg, Germany) and 20006 
(Turku, Finland). All rat experiments were approved by, and conducted in accordance with, 
the guidelines of the Animal Welfare Committee of the University Medical Center 
(Hamburg, Germany).
Isolation of mouse mammary gland cells
Primary mouse mammary stromal fibroblasts (MMFs) and mouse mammary epithelial cells 
(MMEC) were isolated from the mammary glands of adult (17-25 weeks old) virgin female 
mice. Briefly, the 2nd, 3rd, 4th and 5th mammary glands from three wild-type and 
Shank3 挃?−/− mice per experiment were removed aseptically without lymph nodes, minced 
with surgical blades, incubated in a shaker for 2 to 3 h at 37 °C in 25 - 30 ml of digestion 
media (DMEM /F12, 5% FBS, 5 μg/ml insulin, 50 μg/ml gentamicin) containing 2 mg/ml 
collagenase type XI (Sigma). The cell suspensions were centrifuged 10 min at 400 g to 
eliminate floating fat cells. Cell pellets were resuspended in isolation media (DMEM/F12, 
50 μg/ml gentamicin, pen/strep) with 20 U/ml DNase I (Roche) and incubated for 3 min at 
room temperature with occasional shaking. Cells were pelleted and disaggregated by 
pipetting up and down 10 times in 10 ml of isolation media. After each round of pulse 
centrifugation at 400 g, the supernatant containing single cells was collected and pooled. 
After four rounds of pulse centrifugation, the pellet containing mammary epithelial ducts 
was collected. MMECs were trypsinised and pushed through a cell strainer (70 μm, 352350 
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BD Biosciences) to obtain single cells. The supernatants containing MMFs were also 
pelleted, and resuspended in fibroblast growth media (DMEM/F12, 5% FBS, L-glutamine, 
pen/strep). MMEC and MMF cell suspensions were fixed with 4% paraformaldehyde (PFA) 
for 10 min at room temperature and resuspended in PBS.
Primary neuron culture and transfection
For preparation of primary hippocampal and cortical neurons from E20 rat embryos or E16 
Shank3 挃?−/− mice, embryonic brain tissue was dissected, and neurons were recovered by 
enzymatic digestion with trypsin and mechanical dissociation. Cells were maintained in 
Neurobasal medium supplemented with 2% B27 supplement, 0.5 mM L-glutamine, 0.1 
mg/mL primocin and 25 μM glutamate (all from Invitrogen). Cells were transfected with 
pHAGE-EGFP-Shank3 WT or L68P construct using Amaxa Rat neuron nucleofector kit 
(Lonza).
Transient transfections
Lipofectamine 3000 and P3000™ Enhancer Reagent (Thermo Fisher Scientific Inc) were 
used for transient plasmid transfections according to manufacturer’ s protocol and the cells 
were cultured for 24 h. SiRNA silencing was performed using 100 nM siRNA and 
Lipofectamine® RNAiMAX Reagent (Thermo Fisher Scientific Inc) according to 
manufacturer’ s protocol and cells were cultured for 3 days. The siRNAs targeting human 
SHANK1 and SHANK3 were SMARTpool ON-TARGETplus purchased from Dharmacon 
(SHANK1 Cat. No. L-031945-02-0005; SHANK3 Cat. No. L-024645-00-0005). SiRNAs 
used as controls were Allstars negative control siRNA (Qiagen, Cat. No. 1027281) and ON-
TARGETplus Non-targeting Pool (Dharmacon, Cat. No. D-001810-10-05). Rescue 
experiments consisted of plasmid transfections 72 h after siRNA silencing of the protein of 
interest.
cDNA constructs
Rat Shank3-mRFP WT, Shank3R12C-mRFP, Shank3L68P-mRFP and rat Shank1-GFP were 
used in this study. WT and mutant (L68P, R12C) rat Shank3/ProSAP2 cDNAs have been 
described earlier 32. There are two alternative translation start codons in this cDNA (acc. 
NM_021675); we refer here to the second start codon as codon 1, so that the codon for 
Arg12 in the rat Shank3 cDNA corresponds to the (mutated) codon for Arg12 in the human 
SHANK3 gene. cDNAs were subcloned into pmRFP-N3 in frame with the mRFP coding 
sequence for expression of C-terminal mRFP-tagged Shank3 variants. In addition, pHAGE-
EGFP-Shank3 (rat) was kindly supplied by Alex Shcheglovitov (Stanford, CA). The L68P 
mutation was introduced using the QuikChange II mutagenesis kit (Agilent).
For expression of GFP-tagged SPN domain, the sequence coding for the rat Shank3 SPN 
domain was cloned into pEGFP-C1 (Clontech). For the expression of His6-SUMO-tagged 
fusion proteins of N-terminal portions of Shank proteins, appropriate cDNA fragments were 
amplified by PCR using wt or mutant Shank cDNAs as a template, and cloned into pET-
SUMO vectors (Champion™ pET SUMO Protein Expression System, Invitrogen). Protein 
expressed from pET-SUMO-Shank31-348 was used for crystallization and binding assays. 
For introduction of a cleavage site for the tobacco etch virus (TEV) protease, cDNA coding 
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for amino acids SSENLYFQGSS was introduced into this vector between codons for 
Asn100 and Leu101 by a recombinant PCR approach. Human H-Ras was cloned into 
pOPINJ vector (OPPF-UK) encoding an N-terminal hexa-histidine GST tag followed by 3C 
protease cleavage site. Rap1 isoform Rap1b (residues 1-166) was cloned into pTAC vector. 
cDNAs coding for human Rac1 or cdc42 were amplified by PCR and cloned into a modified 
pcDNA3 vector (Invitrogen) with an N-terminal T7 epitope. Constitutively active mutants 
were generated by PCR (initially described in 64). Human SHARPIN-GFP has been 
described in 7. Human constitutively active R-Ras expression clone (pEGFP-R-RasG38V) 
48, human constitutively active Rap1A expression clone (CA-Rap1; pEGFP-C3-
Rap1Q63E), a gift from B. Baum and S. Royale described in 65, the Raichu-Rap1 FRET 
probe, a gift from M. Matsuda. 56, mEmerald-Paxillin-22, a gift from Michael Davidson 
(Addgene plasmid # 54219), GFP-Talin1, mRFP and peGFP-C1 were used in this study.
Antibodies, compounds and reagents
Antibodies used in the study are described in Supplementary Table 2. Phalloidin–Atto 647N 
(65906, Sigma-Aldrich, 1:400) and Alexa Fluor® 488 Phalloidin (A12379, Life 
Technologies, 1:100) were used to stain filamentous actin. AlexaFluor-conjugated secondary 
antibodies (488, 555, 633, 647-conjugated anti-mouse, rabbit, goat, chicken and rat 
antibodies, Life Technologies) were used in immunofluorescence (1:300 or 1:1000 (anti-
chicken)) and FACS (1:200). The 4ᓉ6-diamidino-2-phenylindole (DAPI, Life Technologies 
1:10000) or DAPI-containing mounting medium (ProLong Diamond Antifade Mountant 
with DAPI, Thermo Fisher) were used for nuclear staining. The bovine plasma fibronectin 
(341631) was obtained from Merck. The collagen from calf skin (C8919), poly-L-Ornithine 
solution (P4957) and laminin (L2020) were obtained from Sigma-Aldrich. The laminin-521 
was obtained from BioLamina. Rap1 inhibitor, G5169-GGTI 298 trifluoroacetate salt 
hydrate (Sigma-Aldrich), was dissolved in sterile DMSO.
High-density cell spot microarray (CSMA) screening and Clustergram
The CSMA screening is described in 22. Here, the results of integrin activation using 
SHANK1 and SHANK3 siRNAs are shown. Z-scores were hierarchically clustered on the 
basis of uncentred Pearson correlation using Cluster 3.0 (C Clustering Library, version 1.50) 
66 and visualized using Java TreeView (version 1.1.6r2) 67. RWPE1: immortalized prostate 
cell line; PrEC, PrSC: primary prostate cells; ALVA31, PC3, MDA-PCA2b, 22-RV1 and 
VCaP1: prostatic cancer cell lines; A549 and NCI-H460: lung carcinoma cells; MDA-
MB-231: breast carcinoma cell line; HTC116 and SW480: colon carcinoma cell lines.
GTEx portal analysis
SHANK3 gene expression in human tissues was analysed using the publicly available 
genotype-tissue expression (GTEx) portal (http://www.gtexportal.org/home/gene/SHANK3).
Quantitative real-time polymerase chain reaction (qPCR)
Total cellular RNA was extracted using the NucleoSpin® RNA kit (Macherey-Nagel) and 1 
μg of the extracted RNA was used as a template for cDNA synthesis by high-capacity cDNA 
reverse transcription kit (Applied Biosystems) according to the manufacturer’ s protocol. 
Lilja et al. Page 12
Nat Cell Biol. Author manuscript; available in PMC 2017 September 06.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Expression levels of SHANK 1 and 3 were determined by TaqMan® qPCR reaction using 
Real-Time PCR HT7900 (Applied Biosystems). Level of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) expression was used as a reference (endogenous control). 
Taqman® Universal Master Mix II included necessary components for qRT-PCR reaction. 
The following primers from Sigma were used for human samples: SHANK1 (forward 
CTCCCTGCGTTCCAAATGTA, reverse GGCTGCTGCTCGTACTCC, Universal 
ProbeLibrary probe#25); SHANK3 (forward TTCCACGGACCAAGTCTGTA, reverse 
GTCTTGCATCGAGGTGCTC, probe #11); human GAPDH (forward 
GCTCTCTGCTCCTCCTGTTC, reverse ACGACCAAATCCGTTGACTC, probe #60). 
Relative expression was calculated by the 2ΔΔCT method using the expression level of 
GAPDH as a reference for the quantification.
Western blot assay
Protein extracts were separated on SDS-PAGE under denaturing conditions (4-20% Mini-
PROTEAN®TGX Gels, Bio-Rad) and transferred to nitrocellulose membrane. Membranes 
were blocked with 5%-milk-TBST and incubated with the indicated primary antibodies 
overnight at 4°C followed by fluorophore-conjugated or Amersham ECL HRP-linked 
secondary antibodies at room temperature for 1 h. Membranes were scanned using an 
Odyssey infrared imaging system (Odyssey; LI-COR Biosciences) or Amersham ECL 
Plus™ Western blotting reagent was used and film was developed. Band intensity was 
determined using ImageJ software.
Flow cytometry assays for  ?1-integrin activity
The flow cytometry assay analysing labelled fibronectin (fibronectin) repeat 7-10 binding as 
a measure of active cell-surface  ?1-integrin levels, was performed as described earlier 23, 
24. Cells were detached with Hyclone® HyqTase (cat: SV300.30.01, Thermo Fisher 
Scientific Inc) and washed once with full medium containing 10% FBS. The cells were 
suspended in 100 μl of 37°C serum-free medium with (1) 1:50 Alexa Fluor 647 -labelled 
fibronectin fragment 7-10 (fibronectin7-10), (2) 1:50 fibronectin7-10 supplemented with 5 
mM EDTA (the negative control) or (3) total  ?1-integrin antibody (PB1 for hamster cells, 
P5D2 for human cells, MAB1997 for mouse cells) and 1:200 Alexa-647 conjugated 
secondary antibody. Cells were incubated with rotation for 40 min at room temperature. 
After washing once with cold tyrodes buffer (10 mM Hepes-NaOH pH 7.5, 137 mM NaCl, 
2.68 mM KCl, 0.42 mM NaH2PO4, 1.7 mM MgCl2, 11.9 mM NaHCO3, 5 mM glucose, 
0.1% BSA), the cells were fixed with 4% PFA in PBS for 10 min at room temperature.
For antibody-based analysis of active  ?1-integrin cell-surface levels, the flow cytometry 
assay was performed as described earlier 68. Briefly, PFA-fixed cells were washed with cold 
Tyrodes buffer and stained with active  ?1-integrin specific antibody (1:100 9EG7 for human/
mouse cells) or total  ?1-integrin antibody (P5D2 for human and Mab1997 for mouse cells) 
for 1 h at 4°C. Cells were washed with Tyrodes buffer and followed by incubation with 
fluorescently conjugated secondary antibody for 1 h at 4°C. The negative control cells were 
stained only with secondary antibody. All antibodies were diluted into Tyrodes buffer. The 
fluorescence was measured by flow cytometry (FACScalibur or LSRFortessa, BD 
Biosciences, Franklin Lakes, NJ). The median fluorescence intensity was measured from 
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5000 – 20000 events. Viable, single cells were gated by forward scatter (FSC) and side 
scatter (SSC) dot blot (Flowing Software 2.5.1). In experiments using mRFP and/or GFP 
constructs the mRFP and/or GFP expressing cells were gated (5000 positive cells per 
sample) and analysed for APC (Alexa 647) intensity.
Membrane fractionation
Adherent cells (one 10 cm dish per condition) were washed with PBS and scraped in 500 μL 
of hypotonic lysis buffer (10 mM HEPES-KOH pH 7.2, 0.25 M sucrose, 1 mM EDTA, 1 
mM MgOAc and protease and phosphatase inhibitors (Complete and PhosSTOP tablets from 
Roche)). Cells were fragmented about 20 times with a French press and 40 μL of total lysate 
was saved. The remaining lysate was centrifuged at 1000 g for 10 min to remove nucleus 
and cell debris. The supernatant was then centrifuged at 10000 g to collect total membrane 
fraction (pellet) and cytosolic fraction (supernatant). Membrane fraction was washed at least 
once with lysis buffer and cytoplasmic fraction was centrifuged twice. All fractionation steps 
were performed at 4°C or on ice. All fractions were dissolved in sample buffer for 
immunoblotting and analysed by SDS–PAGE followed by western blotting with the 
indicated antibodies.
Adhesion assay using xCELLigence Real-Time Cell Analysis (RTCA)
The real-time xCELLigence cell analyser RTCA (Roche Diagnostics, Germany) was used to 
measure cell adhesion over time. RTCA measures the impedance that is expressed as a cell 
index. Cell index value presents the impedance between electrodes (bottom sensors). The 
96-well E-plate (Roche) was coated with fibronectin and collagen or 0.1% BSA (Gibco) in 
PBS, followed by blocking with 0.1% BSA in PBS, both at 37°C for 1 h. BSA-coated wells 
were used as negative controls. siRNA-treated and/or transfected cells (HEK293 or MDA-
MB-231) were detached with Hyclone® HyqTase, washed with full medium including 10% 
FBS and 20000 cells/well were seeded on E-plates in serum-free medium. Cell index was 
measured in real-time.
Cell spreading and immunostaining
siRNA-treated and/or transfected cells (HEK293, MDA-MB-231) were maintained in full 
medium and were allowed to spread for 20 min or 1 h on glass-bottom dishes (MatTek 
corporation) previously coated with fibronectin and collagen overnight at 4°C. Transfected 
SK-N-BE-2 cells were plated on laminin-521-coated glass-bottom dishes and differentiated 
using 10 μM retinoid acid in full medium for 3 days. To study the role of Rap1 in SHANK3-
silenced cells, cells were pre-treated with 10 μM Rap1 inhibitor (or DMSO) and plated for 1 
h on fibronectin-collagen in the presence of the inhibitor (or DMSO). Cells were fixed with 
4% PFA, washed, permeabilised with 0.5% Triton-X-100 for 10 min and blocked with 1 M 
Glycine for 30 min at room temperature. Cells were washed and then stained with the 
indicated primary antibodies diluted in PBS (1:100) for 30 min at room temperature. Cells 
were then washed and incubated with Alexa-conjugated secondary antibodies (1:300), 
Phalloidin–Atto 647N (1:400) or Alexa Fluor 488 Phalloidin (1:100), and 4ᓉ6-diamidino-2-
phenylindole (DAPI, nuclei staining, 1:10000) in PBS for 30 min at room temperature.
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Transfected neurons were plated at a density of 4000/mm² (hippocampal) or 20000/mm² 
(cortical) in on 18-mm glass coverslips previously coated with 0.01 % poly-L-Ornithine 
solution (Sigma-Aldrich) for 1 hr at room temperature, followed by 4 μg/ml laminin (Sigma-
Aldrich) in PBS overnight. Cultures were maintained at 37 °C, 5% CO2 in a humidified 
incubator. Neurons were fixed at DIV1 with 4% paraformaldehyde / 4% sucrose in PBS for 
15 min and permeabilised with 0.1% Triton X-100 in PBS for 3 min at room temperature. 
Rat neurons were blocked with 10% horse serum in PBS for 1 h at room temperature, then 
incubated with Map2 (Antibodies online; Aachen, Germany; 1:1000 in 2% horse serum) 
overnight at 4°C, followed by 1 h of incubation at room temperature with Alexa-conjugated 
secondary antibody (1:1000 in PBS) and with 547-Phalloidine (1:40 in PBS) for 20 min at 
room temperature. Nuclei were stained with DAPI-containing mounting medium (ProLong 
Diamond Antifade Mountant with DAPI, Thermo Fisher). Mouse neurons were blocked with 
1 M glycine for 30 min at room temperature, washed and stained using indicated primary 
antibodies diluted in PBS (1:100) for 25 min at RT. Cells were then washed and incubated 
with Alexa-conjugated secondary antibodies (1:300).
Finally, cells were washed and imaged with a confocal microscope. Cell area was analysed 
using ImageJ and the number and size of active integrin (9EG7) positive cell adhesions were 
analysed using the Cell Profiler software. Colocalisation analyses were performed using 
NIH ImageJ Plugin JACop.
Micropatterns
Micropatterns were produced on glass coverslips as previously described 69, 70. Cells were 
seeded on collagen-fibronectin-coated micropattern lines (width 9 μm) for either 20 min or 
60 min (cells on line) before fixing with 4% PFA. Samples were stained as described above.
FRET analysis of active Rap1 localization
siRNA-treated HEK293 cells transiently expressing Raichu-Rap1 FRET probe 71, 72 were 
plated on fibronectin-collagen-coated glass-bottom dishes for 1 h at 37°C. Cells were then 
fixed in 4% PFA, washed with PBS and blocked in a solution of 1 M glycine for 30 min. 
Cells were then imaged with a confocal microscope (LSM780, Zeiss) using an 63x (NA 1.2 
W) objective. The ZEN imaging software was used to generate and export the Fc images 
with intensities converted from the FRET index calculated for each pixel using the Youvan 
method. FRET ratio at the cell edge and cell body was quantified using NIH ImageJ and 
Cell Profiler software.
Proximity Ligation Assay (PLA)
PLA detection of  ?5-integrin-talin interaction was performed as previously described 68. 
Briefly, siRNA-treated HEK293 cells were maintained in full medium and were allowed to 
spread for 20 min on glass-bottom dishes (MatTek corporation) previously coated with 
fibronectin-collagen overnight at 4°C. The coverslips were washed with PBS, fixed with 4% 
PFA for 15 min, washed twice with PBS and permeabilised with 0.5% Triton-X-100 in PBS 
for 15 min at room temperature. Cells were stained using indicated primary antibodies 
diluted in PBS (1:100) for 1 h at room temperature. Proximity ligation was performed 
according to the manufacturer’ s instructions (Duolink in situ PLA, Sigma-Aldrich). PLA 
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signals were detected with a spinning disc confocal microscope (Marianas spinning disk 
imaging system, Intelligent Imaging Innovations, Inc.) using 100x objective (NA 1.4 Oil, 
Plan-Apochromat, M27) and analysed with NIH ImageJ.
Live-cell imaging
To analyse the dynamics of focal adhesions, cells were transfected with mEmerald-Paxillin 
(a gift from Michael Davidson, Addgene plasmid # 54219) and plated for at least 6 h on 
fibronectin-collagen before being imaged live on a TIRF microscope, at 37°C, in presence of 
5% CO2. Images were acquired every minute for at least 3 h, using a 63x (NA 1.46 Oil, 
alpha Plan-Apochromat, DIC) objective and an internal Optovar (1.6x magnification). 
Acquired videos were pre-processed using ImageJ and in particular, the contrast was 
adjusted and a smooth filter was applied. Focal adhesion lifetime was then analysed by 
uploading the videos to the focal adhesion analysis server (FAAS; http://faas.bme.unc.edu/) 
73 using the following settings: detection threshold, 2; Min Adhesion Size, 2 pixels; Min 
FA, Phase Length (8 min); Min FAAI Ratio, 3.
To analyse the dynamics of talin-containing adhesions, cells were transfected with GFP-
Talin-1 and plated on fibronectin-collagen before being imaged live on a TIRF microscope, 
at 37°C, in the presence of 5% CO2. Images were acquired every minute for at least 3 h, 
using a 63x (NA 1.46 Oil, alpha Plan-Apochromat, DIC) objective and an internal Optovar 
(1.6x magnification).
To visualise Shank3 dynamics, cell were transfected with Shank3-mRFP and plated on 
fibronectin-collagen and imaged live on a spinning disk microscope, at 37°C, in the presence 
of 5% CO2. Images were acquired every 10 seconds for about 10 min, using a 100x (NA 1.4 
Oil, Plan-Apochromat, M27) objective and Evolve 512 EMCCD camera (Photometrics, 
Arizona, U.S.).
Cell migration
siRNA-treated and/or transfected cells (MDA-MB-231 or HEK293) were seeded on 
fibronectin-collagen and allowed to spread for 4 h. Cells were maintained at 37°C and 5% 
CO2 and cell migration was monitored using a TIRF microscope (10x objective). Point 
visiting was used to allow multiple positions to be imaged within the same time course and 
images were acquired for 24 h (one picture every ten minutes). To assess cell migration, 
speed and directionality, cells were tracked using the Manual Tracking plug-in of NIH 
ImageJ software. Results were computed and analysed by the NIH ImageJ plug-in 
Chemotaxis Tool.
Inverted invasion assay
Inverted invasion assay was performed as previously described 74. In brief, 200 μl of 
collagen I (5 μg/ml; PureCol® EZ Gel, Cat. #5074-G, Advanced BioMatrix Inc., SanDiego, 
CA, USA) supplemented with 25 μg/ml fibronectin was allowed to polymerize in each 
transwell chamber, i.e. insert (ThinCert™, pore size 0.8 μm, Greiner bio-one) for 1 h at 
37°C. Transwells were then inverted, and 100000 MDA-MD-231 cells in full medium were 
seeded directly onto the underside of each transwell filter. The droplets of cell suspension 
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were covered and incubated for 4 h at 37°C in a humidified incubator to allow cells to attach 
to the membranes. Transwell chambers were then washed with serum-free medium to 
remove serum. Finally, transwells were placed in serum-free medium, and medium 
supplemented with 10% FCS was placed on top of the collagen plug to make a 
chemoattractant gradient. Transwells were incubated at 37°C for 72 h. Then, collagen plugs 
were fixed with 4% PFA for 2 h and stained for actin (Åtto Phalloidin 647) to visualize cells. 
The plugs were imaged by confocal microscopy (Zeiss LSM510 META) controlled by the 
Zen2009 Systems Software (Carl Zeiss). Serial optical sections were imaged at 15 μm 
intervals with a 20x objective lens (NA 0.50 air, Plan-neofluar). Invasion was quantified 
using the area calculator plugin in ImageJ to measure fluorescence intensities of cells as a 
ratio of cells invading 45 μm or more into the collagen plug relative to total amount of cells 
within the plug.
Microscopy
Confocal images were acquired with a laser scanning confocal microscope LSM780 (Carl 
Zeiss Microscopy, Thornwood, NY) using a 63x (NA 1.2 W) objective; or with a spinning 
disk confocal microscope (Marianas spinning disk imaging system with a Yokogawa CSU-
W1 scanning unit on an inverted Carl Zeiss Axio Observer Z1 microscope, Intelligent 
Imaging Innovations, Inc., Denver, USA) using a 63x (NA 1.4 Oil, Plan-Apochromat, M27 
with DIC III Prism) objective and an Orca Flash 4 sCMOS camera (Hamamatsu Photonics 
K.K., Hamamatsu City, Japan) or 100x (NA 1.4 Oil, Plan-Apochromat, M27) objective and 
an Evolve 512 EMCCD camera (Photometrics, Arizona, U.S.); or with LSM510 META 
(Carl Zeiss Microscopy, Thornwood, NY) using 20 x objective (NA 0.50 air, Plan-Neofluar); 
or with a Leica Sp5 confocal microscope using a 63x objective (NA 1.4). Images with a 
TIRF microscope (Zeiss Laser-TIRF 3 Imaging System, Carl Zeiss) were acquired using a 
10x objective (NA 0.25 air) or a 63x (NA 1.46 Oil, alpha Plan-Apochromat, DIC) objective 
with an internal Optovar (1.6x magnification) and an EMCCD camera (Hamamatsu 
ImageEM C9100-13; Chip size 512x512; Hamamatsu Photonics K.K., Hamamatsu City, 
Japan). Quantitative analysis for images was performed using ImageJ or Cell Profiler 
software.
Immunoprecipitation of GFP-tagged proteins
HEK293 cells were transiently transfected with GFP-tagged Shank3 SPN constructs and 
 ?T7 or HA-tagged small G-proteins. Cells were lysed using IP buffer (50 mm Tris/HCl, pH 
7.5, 120 mm NaCl, 0.5% Nonidet P-40, 1 mm EDTA, plus protease inhibitors pepstatin, 
leupeptin, and trasylol), cleared by centrifugation, and subjected to immunoprecipitation of 
GFP-tagged fusion proteins using GFP-trap matrix (Chromotek, Munich, Germany). Input 
and precipitate samples were analysed by Western blot. Bands were quantified by 
chemilumiscence, using a BioRad imager and ImageLab software (BioRad). For 
quantification of co-precipitation efficiency, intensity of precipitate signals was divided by 
input signals. In a second step, the ratio obtained was normalized to that obtained with SPN 
WT domain.
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Immunoprecipitation of endogenous proteins
Cells were detached with trypsin, spin down and excess liquid was removed. A total of 200 
μL of lysis buffer (40 mM Hepes-NAOH, 75 mM NaCl, 2 mM EDTA, 1% NP40 and 
protease and phosphatase inhibitor tablets) was added (per 10 cm plate). Tubes containing 
the lysates were rotated for 30 min at 4°C. Lysates were then spin down at 13000 rpm 
(ᙺ16000 g) for 10 min at 4°C and debris was discarded. A total of 20 μL of supernatant was 
frozen as lysis control. The remainder of the sample was moved to new 1.5 ml tubes and 1.5 
μg of antibodies added per sample. The tubes were then incubated overnight at 4°C. Lysates 
were immunoprecipitated with protein G Sepharose 4 Fast Flow beads (GE Healthcare) for 1 
h at 4°C. Finally, immunoprecipitated complexes were washed three times with wash buffer 
(20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40) followed by elution in reducing 
Laemmli buffer and denatured for 5 min at 95°C for western blotting.
Rap1 activity assay
The level of active Rap1 in control and SHANK3-silenced cells was analysed using the 
Active Rap1 Pull-Down and Detection Kit (Thermo Fisher). SiRNA transfected HEK293 
cells were lysed and active Rap1 binding to purified GST-RalGDS Rap-binding domain 
(RBD) was analysed according to manufacturer’ s instructions using pull-downs followed by 
western blot detection.
Sample preparation for structural and ITC binding analysis
Rat SHANK3 (residues 1-348) was expressed using BL21 competent cells (Invitrogen) 
cultured in LB (Luria Broth) for crystallization and ITC, or M9 minimal medium for NMR 
analysis. Cells were grown at 37°C in LB media supplemented with antibiotics to an OD600 
of 0.7, cells were cooled to 18°C and induced using 300 μM IPTG (Isopropyl  ?-D-1-
thiogalactopyranoside) for 16 h. Cells were pelleted by centrifugation and resuspended in 20 
mM Na2HPO4 pH 7.4, 500 mM NaCl and 25 mM imidazole, cells were then treated with 
protease cocktail inhibitor VII (Calbiochem) and bovine deoxyribonuclease (1 mg/ml) 
before being lysed using a French Press. Proteins were purified using nickel-affinity 
chromatography with a linear gradient of lysis buffer containing 500 mM imidazole. SUMO 
tag was cleaved with recombinant His-tagged sumo protease and removed by a reverse pass 
on the Ni-NTA column. Following this step the SHANK3 was shown to have > 95% purity 
by SDS-PAGE chromatography. SHANK3 was then exchanged into 20 mM Tris pH 7.4, 150 
mM NaCl, 2 mM DTT (dithiothreitol) and concentrated to 6 mg/ml for crystallization 
experiments. H-Ras was expressed using Rosetta pLacI (Invitrogen) cells and purified using 
nickel affinity chromatography as described for SHANK3. The GST tag was cleaved with 
recombinant his-tagged 3C protease and removed by a reverse pass on the Ni-NTA column. 
H-Ras required subsequent purification using anion exchange purification using a QFF 
column (GE healthcare) and was shown to be > 95% pure by SDS-PAGE chromatography. 
Rap1b was expressed in E. coli strain CK600K. Cultures were grown at 37°C to OD595 of 
0.8 and then induced with 200 μM IPTG at 18°C overnight. Protein was purified by ion 
exchange, followed by gel filtration, as described in 75. Active GTP form of Ras and Rap1b 
was produced by nucleotide exchange as described in 76 using non-hydrolysable GTP 
analogue GMPPCP. GDP form was generated by overnight incubation of GTPase in the 
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presence of 50 fold molar excess of GTP in the presence of EDTA to remove magnesium, 
followed by the buffer exchange using PD10 column (GE healthcare). Completeness of the 
exchange was validated by NMR spectroscopy.
X-ray crystallography
Sparse matrix crystal screening of SHANK3 (1-348) was performed using an innovadyne 
nanodrop screen maker at protein concentration of 6 mg/ml with a 200 nl drop size (1:1 
ratio) using sitting drop vapour diffusion. Crystals typically appeared in over 20 conditions 
overnight, and thus optimization was not necessary. High resolution data was collected on 
crystals grown in 0.1 M HEPES pH 7.5, 0.4 M K/Na tartrate and were vitrified using 30% 
ethylene glycol, 10% isopropanol. An 180° wedge of data was collected at Diamond Light 
Source (I04-1) with a non-overlapping 0.5° oscillation width. Owing to systematic absences 
the data was indexed (Pointless) and integrated (MOSFLM) in p41212 and then scaled 
(SCALA). Molecular replacement was performed using PHASER examining all 
enantiomorphs, implementing a fragment from an ankyrin repeat module with side chains 
removed from PDB:1N11. Upon isotropic refinement using PHENIX.refine 77 electron 
density for the full ankyrin repeat was visible and modelled using COOT 78. This revealed 
the presence of the SPN domain in the weighted difference map that was subsequently 
modelled at 1 ?. The fully refined electron density map also revealed a significant amount of 
ethylene glycol and isopropyl alcohol from the cryo-protectant bound to the structure. These 
bound molecules were assigned and accounted for in the final refinement. Data reduction 
and refinement statistics are shown in Supplementary Table 1.
NMR spectroscopy
NMR spectra were collected on a Bruker Avance III 600 and 800 MHz spectrometers 
equipped with CryoProbes. Experiments were performed at 298 K in 20 mM Tris pH 7.4, 
150 mM NaCl, 2 mM DTT, with 5% (v/v) 2H2O. Spectra were processed with TopSpin 
(Bruker).
Isothermal titration calorimetry (ITC)
ITC experiments were performed using an ITC-200 (Microcal). ITC titrations performed in 
20 mM Tris pH 7.4, 150 mM NaCl, 0.5 mM TCEP (tris-carboxyethyl-phosphine) and 3 mM 
MgCl2 at 25°C. Data were integrated and fitted to a single-site binding equation using 
Origin 7 software with integrated ITC module (Microcal).
Statistics and Reproducibility
Statistical testing was determined using the Student’ s t-test (unpaired two-tailed, unequal 
variance) or ANOVA (followed by Dunnett’ s test for multiple comparisons, where 
appropriate). All experiments were repeated at least three times unless otherwise indicated. 
N numbers are indicated in the figure legends. P-value of 0.05 was considered as a 
borderline for statistical significance (P > 0.05). P-values are indicated in the figures. The 
experiments were not randomized. No statistical method was used to determine sample size. 
Investigators were not blinded to allocation during experiments and outcome assessment 
except for FACS assays.
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Data Availability
Atomic coordinates for the reported crystal structure have been deposited in the Protein Data 
Bank under the accession code 5G4X. Source data for figures 1e, 2a, 3b, 5a, and 
supplementary figures S1e, S1f, S2a, S5a and S5b can be found in Supplementary Table 3. 
All other data supporting the findings of this study are available from the corresponding 
author on reasonable request.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. SHANK1 and SHANK3 inhibit  ?1-integrin activation
a, Hierarchical clustering of  ?1-integrin activity (9EG7 and/or 12G10 antibodies; red: 
increased and blue: decreased compared to control-silenced cells (Z-score)) in 13 human cell 
lines upon SHANK1 or SHANK3 silencing with two independent siRNAs (#1 or #2). 
Results taken from a high-density cell-spot microarray.
b, SHANK3 gene expression (log10RPKM: Reads Per Kilobase of transcript per Million 
mapped reads) in human tissues analysed using the publicly available GTEx portal (Grey 
region: brain tissues).
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c-e, Flow cytometric (FACS) analysis of integrin activity in the indicated conditions. c, 
Quantification shows reduced active cell-surface integrin (FN 7-10 binding) relative to total 
cell-surface  ?5 ?1-integrin (PB1 antibody) in Shank3-mRFP- or SHARPIN-GFP-expressing 
cells compared to mRFP/GFP cells. d, SHANK3-silencing triggers  ?1-integrin activation 
(active  ?1-integrin: 9EG7 antibody; total  ?1-integrin: P5D2) similarly to Mn2+. e, Shank3-
mRFP re-expression abrogates integrin activation induced by SHANK3 silencing. Data 
represent mean ± SEM (n = 5 (c), 3 (d), 4 (e) independent experiments; 5000 (mRFP- or 
GFP-positive cells) or 10000 cells (SHANK3-silenced) per experiment).
f, FACS analysis (active  ?1-integrin: 9EG7 antibody; total  ?1-integrin: MAB1997) in 
MMECs isolated from Shank3 挃?−/− mice compared to Shank3 挃?+/+ (mean of 2 
independent experiments; cells pooled from three mice per experiment).
g, Shank3-mRFP-expressing MDA-MB-231 cells plated on fibronectin-collagen 
demonstrate SHANK3 localization with inactive  ?1-integrin (MAB13) and membrane 
marker CAAX-GFP in membrane ruffles. Shown is a representative confocal slice (middle 
plane). ROI: region of interest. Scale bar = 20 μm (original image) and 10 μm (ROI).
h, HEK293 subcellular fractions. Cyt: cytoplasmic; PM: plasma membrane; Na+/K+ pump: 
PM marker; tubulin: Cyt marker; 10 % Lys: 10 % of total lysate.
i, Shank3-mRFP-expressing MDA-MB-231 cells plated on fibronectin and imaged live using 
a spinning disk microscope (1 picture every 10 s). Scale bar = 20 μm (original image) and 5 
μm (ROI).
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Statistics source data can be found 
in Supplementary Table 3. Unprocessed original scans of blots are shown in Supplementary 
Fig 8.
Lilja et al. Page 26
Nat Cell Biol. Author manuscript; available in PMC 2017 September 06.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2. Loss of SHANK1 and SHANK3 promotes cell adhesion and spreading
a, Rate of cell adherence (cell index) of HEK293 cells monitored in real-time using the 
xCELLigence system shows enhanced cell attachment upon SHANK3 silencing on a 
fibronectin-collagen substrate. BSA was used as a control for background binding. Data 
represent mean ± SEM (n = 4 independent experiments; average of 4 wells per experiment, 
20000 cells/well).
b, Representative confocal images of control- and SHANK3-silenced HEK293 cells 
adhering to a fibronectin-collagen substrate for 15 min. Cells were stained for active  ?1-
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integrin (9EG7, green), paxillin (grey) and F-actin (phalloidin, red) to mark adhesions. 
Shown are confocal slices from the bottom surface. Scale bar = 10 μm (original image) and 
5 μm (ROI).
c-e, Quantification of the active integrin (9EG7-positive) adhesions in b showing that 
SHANK3-silenced HEK293 cells form more (c) but smaller (d) adhesions as compared to 
control-silenced cells. The distribution of adhesion size is also shown (e). Adhesions were 
analysed using the Cell Profiler software. Data shown as Tukey box plots (n = 15 siCTRL 
cells and 22 siSHANK3 cells from 3 independent experiments).
f,g, Representative confocal images (f) and quantification (g) showing increased HEK293 
cell spreading on a fibronectin-collagen substrate upon SHANK3 silencing. Cells were 
stained for F-actin (phalloidin). Scale bar = 7 μm. Quantification of cell area at 20 or 60 min 
post-plating was analysed using Image J. Data displayed as Tukey box plots (n = 47 cells (20 
min) or 72 cells (60 min) from 3 independent experiments).
h,i, Representative confocal images (h) and quantification (i) showing increased HEK293 
cell length upon SHANK3 silencing compared to control cells on fibronectin-collagen-
coated micropattern lines at 20 or 60 min post-plating. Scale bar = 10 μm. Data are 
displayed as Tukey box plots (n = 29 cells (20 min) or 46 cells (60 min) from 3 independent 
experiments).
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Statistics source data can be found 
in Supplementary Table 3.
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Figure 3. Structural analysis of the SHANK3 SPN-ARR region
a, Illustration of SHANK3 protein domains. SPN: Shank/ProSAP N-terminal domain; ARR: 
ankyrin repeat domain; SH3: Src homology 3 domain; PDZ: PSD-95/Discs large/ZO-1 
domain; PP: proline-rich region; SAM: sterile alpha motif domain. ASD-related mutations 
(R12C, L68P) in the SPN domain are indicated.
b,c, FACS analysis of integrin activity. b, Re-expression of Shank3-mRFP L68P or R12C in 
SHANK3-silenced HEK293 cells has no effect on integrin activity. c, Expression of SPN 
WT-GFP alone inhibits integrin activity in CHO cells. Data represent mean ± SEM (n = 4 
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(b), 5 (c) independent experiments; 5000 mRFP or GFP-positive cells analysed per 
experiment). Bars shown as dashed line are from Fig. 1e.
d,e, HEK293 cell adhesion and spreading monitored as in 2a and 2g. Re-expression of WT 
Shank3-mRFP, but not L68P mutant, decreases cell adhesion (d) and spreading (20 min) (e) 
induced by SHANK3 silencing. (d) Data represent mean ± SEM (n = 6 independent 
experiments; average of 4 wells per experiment, 20000 cells/well). (e)Tukey box plots are 
shown (n = 138, 224, 99, 101 cells from left to right) from 3 independent experiments.
f,g, Representative confocal images (f) and quantification (g) of integrin activity in 
Shank3 挃?−/− mouse cortical neurons plated on laminin. Overexpression of SHANK3 WT, 
but not the L68P mutant, reduces active integrin (9EG7) in growth cones relative to area. 
Scale bar = 5 μm. Mean grey value (active integrin intensity) analysed with Image J software 
(g). Data represent mean ± SEM (n = 40 (WT) or 34 (L68P) growth cones from 3 
independent experiments; cells pooled from 7-8 embryos per experiment).
h, Cartoon representation of the SPN-ARR crystal structure. The SPN domain is shown in 
cyan, linker region in orange and ARR domain in green. Side-chains of R12 and L68, 
mutated in ASD, are depicted as red sticks.
i, Superposition of SHANK3 SPN (cyan) and talin F0 (grey) domain structures.
j, Interface between SPN and ARR domains showing side-chains of the contacting residues 
as sticks. Polar oxygen atoms are highlighted in red and nitrogen in blue. Protein orientation 
was changed slightly relative to (h) to optimize side-chain representation.
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Statistics source data can be found 
in Supplementary Table 3.
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Figure 4. SHANK3 interaction with Ras and Rap
a, Alignment of SHANK1 (rat, Q9WV48) and SHANK3 (rat, Q9JLU4) protein sequences 
with the Ras/Rap recognition elements of known RA domains (Ra1GDS: rat, Q03386; C-
Raf: human, P04049; Byr: yeast, P28829). Consensus recognition sequence is indicated 
above. Key hydrophobic and charged residues are highlighted in colour. Note that the 
hydrophobic residues are part of the hydrophobic core that defines the conformation of the 
Ras/Rap binding region.
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b, Superposition of SHANK3 SPN (cyan) and RalGDS RA (PDB ID 1LFD) (grey) domain 
structures. Key positively- and negatively-charged side-chains in both proteins are shown as 
sticks.
c, Electrostatic surface of the SPN domain highlighting the location of positive charges 
(blue) aligned with key charged residues mediating Ras/Rap interaction with RA domains.
d, SHANK3 SPN WT-GFP, co-expressed with constitutively active (G12V), wild-type 
(WT), or dominant negative (S17N) HA-tagged H-Ras in HEK293 cells, was 
immunoprecipitated (IP) from cell lysates, and input lysates and IP samples were analysed 
using anti-GFP and anti-HA antibodies, as indicated.
e, SHANK3 SPN WT-GFP domain co-expressed with HA-tagged WT and mutant Ras 
family of G-proteins, as indicated. GFP-containing proteins were IP from cell lysates, and 
input lysates and IP samples were analysed as in d.
f, Model of the SHANK3 SPN domain in complex with Ras based on the structure of 
RalGDS/active H-Ras complex (PDB ID 1LFD).
g, WT and mutant SHANK3 SPN constructs co-expressed with constitutively active (G12V) 
forms of small GTPases H-Ras, Rap1a and Rap1b. GFP-containing proteins were IP from 
cell lysates and analysed as in d.
h, Quantification of the data in g; binding efficiency for each HA-tagged G-protein was 
determined as the ratio of IP to input signal. Ratios obtained with different SHANK3 (WT 
and mutant) SPN constructs were normalized to SPN WT in each condition (n = 5 (H-Ras) 
or 4 (Rap1a, Rap1b) experiments; Statistical analysis: ANOVA, followed by Dunnett's 
multiple comparisons test prior to normalization).
i,j, ITC isotherms for active Rap1b interaction with WT SHANK3 SPN-ARR (i) or with 
SHANK3 SPN(R12C)-ARR mutant (j). Solid lines indicate fitting to the single-site-binding 
model. Active GTP form of Rap1 was produced using non-hydrolysable GTP analogue 
GMPPCP. Unprocessed original scans of blots are shown in Supplementary Fig 8.
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Figure 5. SHANK3 regulates integrin activation and cell spreading by a Rap1/Ras-dependent 
mechanism
a, FACS analysis shows that SHANK3 WT-mRFP, but not SHANK3 mutant, overexpression 
prevents Rap1Q63E-mediated  ?1-integrin activation in HEK293 cells. Data represent mean 
± SEM relative to mRFP and GFP expressing cells (n = 4 independent experiments; 5000 
mRFP/GFP-positive cells analysed per experiment).
b,c, Representative confocal images (b) and quantification (c) of spreading MDA-MB-231 
cells transfected with GFP-Rap1Q63E alone or together with SHANK3 WT-mRFP. 
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Staining: F-actin and DAPI (cell nuclei). Middle plane confocal image is shown. Scale bar: 
10 μm. Tukey box plots represent median cell area relative to untransfected cells (n = 26, 21, 
27 cells from left to right from three independent experiments).
d,e, Representative confocal images (d) and quantification (e) of filopodia (indicated by 
arrowheads) in rat hippocampal neurons plated on laminin. Staining: F-actin and Map2 
(neurite marker). Tukey box plots are shown (n = 176 (WT), 120 (L68P) from two 
independent experiments). Scale bar = 20 μm (original image) and 10 μm (ROI).
f,g, Representative confocal images (f) and quantification (g) of filopodia in SK-N-BE-2 
neuroblastoma cells plated on laminin and differentiated with retinoid acid (10 μM, three 
days). Shank3 SPN WT-GFP overexpression reduces filopodia density in neurites. Tukey 
box plots are shown (n = 76 (GFP), 62 (WT), three independent experiments). Scale bar = 
20 μm.
h, FACS analysis of  ?1-integrin activity in SHANK3-silenced HEK293 cells treated with a 
Rap1 inhibitor (10 μM, 1 h). (f) Data are mean ± SEM (n = 5 independent experiments; 
10000 cells per experiment).
i,j, Representative images (i) and Image J quantification (j) of cell area in SHANK3-silenced 
HEK293 cells ± Rap1 inhibitor (10 μM, 1 h). Cells were adhering on a fibronectin-collagen 
matrix (15 min). Middle plane confocal image is shown. Scale bar = 10 μm. Data are 
represented by Tukey box plots (n = 30, 33, 38 cells from left to right from two independent 
experiments.
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Statistics source data can be found 
in Supplementary Table 3.
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Figure 6. Loss of Shank3 promotes active Rap1 localisation to the cell edge.
a, Representative images and quantification of colocalization between Shank3 and 
constitutively active Rap1 (n = 18 cells from 3 independent experiments). R: Pearson’ s 
correlation coefficient. Scale bar = 20 μm (original image) and 10 μm (ROI). b, Subcellular 
membrane fractionation showing increased Rap1 in the membrane fraction of SHANK3-
silenced HEK293 cells. Representative blots are shown (numbers indicate mean ± SEM 
from three independent experiments).
c-e, HEK293 cells transiently expressing Raichu-Rap1 FRET probe (imaged for YFP and 
CFP on a confocal microscope) showing higher Rap1 activity (higher FRET ratio) at the cell 
periphery of SHANK3-silenced cells as compared to control-silenced cells. Representative 
images (left panels: YFP fluorescence; right panels: FRET ratio; scale bar = 10 μm) are 
shown (c). FRET ratio at the cell edge and cell body quantified using ImageJ software are 
presented as Tukey box plots (n = 23 cells from three independent experiments) (d) and the 
distribution of the FRET signal (mean ± SD; four diametric a-b measurements / cell, n = 252 
measurement from three independent experiment) is shown (e).
Lilja et al. Page 35
Nat Cell Biol. Author manuscript; available in PMC 2017 September 06.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Unprocessed original scans of blots 
are shown in Supplementary Fig 8.
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Figure 7. SHANK1 and SHANK3 sequester active Rap1 to inhibit RIAM/talin-dependent 
integrin activation and alter adhesion dynamics
a,b, Representative PLA signal (red dots) (a) and quantification of the distribution of the 
PLA signal relative to the total cell area (F-actin) (b) revealing more co-localization between 
talin and  ?5-integrin following SHANK3 silencing in HEK293 cells. Data are displayed as 
Tukey box plots and expressed relative to control-silenced cells (n = 72 cells from three 
independent experiments).
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c,  ?1-integrin (P5D2) immunoprecipitation showing enhanced interaction between  ?1-
integrin and talin following SHANK3 silencing in HEK293 cells (representative blot from 
four independent experiments is shown).
d,e, MDA-MB-231 cells transiently expressing GFP-Talin1 were plated on fibronectin-
collagen and imaged live using a TIRF microscope (1 picture every 1 min for more than 3 h; 
scale bar = 20 μm (original image) and 10 μm (ROI)) (d). The percentage of cells displaying 
a “talin wave” was then counted (three biological repeats; 84 siCTRL and 86 siSHANK1 
movies analysed) (e).
f,g, MDA-MB-231 cells transiently expressing mEmerald-Paxillin were plated on 
fibronectin-collagen and imaged live using a TIRF microscope (1 picture every 1 min for 
more than 3 h; scale bar = 20 μm) (f). Focal adhesion lifetime was analysed using the focal 
adhesion analysis server (see methods) (two biological repeats; over 33 movies per condition 
analysed; n = 97817 siCTRL and 164092 siSHANK1 adhesions analysed) (g).
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test. Unprocessed original scans of blots 
are shown in Supplementary Fig 8.
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Figure 8. SHANK1 and SHANK3 regulate cell migration and invasion
a-e, MDA-MB-231 cell migration on a fibronectin-collagen matrix recorded over 24 h by 
time-lapse imaging showing that SHANK1-silenced cells migrate faster and more randomly 
than control-silenced cells (a-c). Re-expression of Shank1-GFP in SHANK1-silenced cells 
rescued defects observed in cells migration (d, e). Representative cell tracks over 10 h (a) 
and quantification of the migration speed (b, d) and directionality (c, e) over 24 h are shown. 
Data were analysed using the Manual Tracking plugin (ImageJ) and are displayed as Tukey 
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box plots (n = 36 (siCtrl) and 37 (siSHANK1) from three independent experiments (b and 
c); n = 36, 29, 28 from left to right from three independent experiments (d and e)).
f,g, Inverted invasion assay showing increased MDA-MB-231 cell invasion upon SHANK1 
silencing. Invasion in collagen plugs supplemented with fibronectin was visualized using a 
confocal microscope by imaging serial optical sections at 15 μm intervals. Individual 
confocal images are shown in sequence with increasing penetrance from left to right (f). 
Invasion was quantified using ImageJ by measuring the fluorescence intensity of cells 
invading 45 μm or more and expressing this as a ratio of the fluorescence intensity of all 
cells within the plug. Data are presented as Tukey box plots (g) (n = 6 means from three 
independent experiments).
h, Schematic representation of SHANK-Rap1–dependent integrin inactivation regulating 
cell adhesion, spreading, migration and invasion.
Tukey box plots represent median and 25th and 75th percentiles (interquartile range); points 
displayed as outliers if 1.5 times above or below the interquartile range; outliers are 
represented by dots. Statistical analysis: Student’ s t-test.
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